Form 4: Aethlon Medical Director Chetan Shah Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Chetan Shah reports acquiring 32,894 shares of Aethlon Medical common stock at $1.52 per share and disposing of 44,532 shares.
Summary
- On April 16, 2024, Chetan Shah, a director of Aethlon Medical Inc., reported a transaction involving the company's common stock.
- Shah acquired 32,894 shares at a price of $1.52 per share.
- Simultaneously, Shah disposed of 44,532 shares.
- Following these transactions, Shah directly owns 44,532 shares of Aethlon Medical Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect broader industry trends but offers insight into the actions of a key individual within Aethlon Medical.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 04/16/2024 | Date of stock acquisition and disposal. |
| 04/17/2024 | Date of signature on the Form 4 filing. |
| 06/30/2024 | First vesting date of RSUs. |
| 09/30/2024 | Second vesting date of RSUs. |
| 12/31/2024 | Third vesting date of RSUs. |
| 03/31/2025 | Fourth vesting date of RSUs. |
Keywords
Aethlon Medical, AEMD, Chetan Shah, Form 4, Director, Stock Transaction, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.